Naringenin has anti-inflammatory properties in macrophage and ex vivo human whole-blood models

Journal of Periodontal Research

Volumn 43, Issue 4, 2008, Pages 400-407

  Bodet, C ^a   La, V D ^a   Epifano, F ^b   Grenier, D ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Aggregatibacter actinomycetemcomitans; Cytokine; Flavanone; Lipopolysaccharide; Naringenin; Periodontitis

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID; FLAVANONE DERIVATIVE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; NARINGENIN; PHOSPHOTRANSFERASE; PROTEIN C JUN; PROTEIN SERINE THREONINE KINASE; SERINE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ARTICLE; BLOOD; CELL STRAIN U937; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; ESCHERICHIA COLI; HUMAN; MACROPHAGE; PERIODONTITIS; PHOSPHORYLATION;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANTI-INFLAMMATORY AGENTS; ESCHERICHIA COLI; FLAVANONES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MACROPHAGES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERIODONTITIS; PHOSPHORYLATION; PHOSPHOTRANSFERASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-JUN; SERINE; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 45549094966     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2007.01055.x     Document Type: Article

References (40)

1. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993 28 : 500 510.
2. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998 9 : 248 266.
3. Henderson B, Poole S, Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 1996 60 : 316 341.
4. Henderson B, Wilson M, Sharp L, Ward JM. Actinobacillus actinomycetemcomitans. J Med Microbiol 2002 51 : 1013 1020.
5. Slots J, Listgarten MA. Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. J Clin Periodontol 1988 15 : 85 93.
6. Tiranathanagul S, Yongchaitrakul T, Pattamapun K, Pavasant P. Actinobacillus actinomycetemcomitans lipopolysaccharide activates matrix metalloproteinase-2 and increases receptor activator of nuclear factor-kappaB ligand expression in human periodontal ligament cells. J Periodontol 2004 75 : 1647 1654.
7. Ueda N, Koide M, Ohguchi M et al. Involvement of prostaglandin E2 and interleukin-1 alpha in the differentiation and survival of osteoclasts induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4. J Periodont Res 1998 33 : 509 516.
8. Bodet C, Chandad F, Grenier D. Anti-inflammatory activity of a high-molecular-weight cranberry fraction on macrophages stimulated by lipopolysaccharides from periodontopathogens. J Dent Res 2006 85 : 235 239.
9. Paquette DW, Williams RC. Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases. Periodontol 2000 2000 24 : 239 252.
10. Francis AR, Shetty TK, Bhattacharya RK. Modulating effect of plant flavonoids on the mutagenicity of N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis 1989 10 : 1953 1955.
11. Lee CH, Jeong TS, Choi YK et al. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem Biophys Res Commun 2001 284 : 681 688.
12. So FV, Guthrie N, Chambers AF, Carroll KK. Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett 1997 112 : 127 133.
13. Raso GM, Meli R, Di Carlo G, Pacilio M, Di Carlo R. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci 2001 68 : 921 931.
14. Shiratori K, Ohgami K, Ilieva I et al. The effects of naringin and naringenin on endotoxin-induced uveitis in rats. J Ocul Pharmacol Ther 2005 21 : 298 304.
15. Hassell TM. Tissues and cells of the periodontium. Periodontol 2000 1993 3 : 9 38.
16. Yamalik N, Delilbasi L, Gulay H, Caglayan F, Haberal M, Caglayan G. The histological investigation of gingiva from patients with chronic renal failure, renal transplants, and periodontitis: a light and electron microscopic study. J Periodontol 1991 62 : 737 744.
17. Attstrom R. Presence of leukocytes in crevices of healthy and chronically inflamed gingivae. J Periodont Res 1970 5 : 42 47.
18. Kowashi Y, Jaccard F, Cimasoni G. Sulcular polymorphonuclear leucocytes and gingival exudate during experimental gingivitis in man. J Periodont Res 1980 15 : 151 158.
19. Zappa U, Reinking-Zappa M, Graf H, Espeland M. Cell populations and episodic periodontal attachment loss in humans. J Clin Periodontol 1991 18 : 508 515.
20. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 1997 14 : 33 53.
21. Darveau RP, Hancock RE. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol 1983 155 : 831 838.
22. Rovera G, Santoli D, Damsky C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci USA 1979 76 : 2779 2783.
23. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003 74 : 391 401.
24. Herath HM, Takano-Ishikawa Y, Yamaki K. Inhibitory effect of some flavonoids on tumor necrosis factor-alpha production in lipopolysaccharide- stimulated mouse macrophage cell line J774.1. J Med Food 2003 6 : 365 370.
25. Hougee S, Sanders A, Faber J et al. Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages. Biochem Pharmacol 2005 69 : 241 248.
26. Tsai CC, Ho YP, Chen CC. Levels of interleukin-1 beta and interleukin-8 in gingival crevicular fluids in adult periodontitis. J Periodontol 1995 66 : 852 859.
27. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodont Res 2001 36 : 194 203.
28. Bodet C, Chandad F, Grenier D. Porphyromonas gingivalis-induced inflammatory mediator profile in an ex vivo human whole blood model. Clin Exp Immunol 2006 143 : 50 57.
29. Nakamura T, Nitta H, Ishikawa I. Effect of low dose Actinobacillus actinomycetemcomitans lipopolysaccharide pretreatment on cytokine production by human whole blood. J Periodont Res 2004 39 : 129 135.
30. Hou LT, Liu CM, Rossomando EF. Crevicular interleukin-1 beta in moderate and severe periodontitis patients and the effect of phase I periodontal treatment. J Clin Periodontol 1995 22 : 162 167.
31. Lima V, Vidal FD, Rocha FA, Brito GA, Ribeiro RA. Effects of tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide on alveolar bone loss in short-term experimental periodontal disease in rats. J Periodontol 2004 75 : 162 168.
32. Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 1998 160 : 403 409.
33. Morse D, Pischke SE, Zhou Z et al. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 2003 278 : 36993 36998.
34. Mukaida N, Okamoto S, Ishikawa Y, Matsushima K. Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 1994 56 : 554 558.
35. Spriggs DR, Deutsch S, Kufe DW. Genomic structure, induction, and production of TNF-alpha. Immunol Ser 1992 56 : 3 34.
36. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995 270 : 16483 16486.
37. Minden A, Karin M. Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta 1997 1333 : 85 104.
38. Allister EM, Borradaile NM, Edwards JY, Huff MW. Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes. Diabetes 2005 54 : 1676 1683.
39. Woo CH, Massett MP, Shishido T et al. ERK5 activation inhibits inflammatory responses via peroxisome proliferator-activated receptor delta (PPARdelta) stimulation. J Biol Chem 2006 281 : 32164 32174.
40. Feldmann M, Brennan FM, Maini R. Cytokines in autoimmune disorders. Int Rev Immunol 1998 17 : 217 228.